176 research outputs found

    State Dependence and Alternative Explanations for Consumer Inertia

    Get PDF
    For many consumer packaged goods products, researchers have documented a form of state dependence whereby consumers become "loyal" to products they have consumed in the past. That is, consumers behave as though there is a utility premium from continuing to purchase the same product as they have purchased in the past or, equivalently, there is a psychological cost to switching products. However, it has not been established that this form of state dependence can be identified in the presence of consumer heterogeneity of an unknown form. Most importantly, before this inertia can be given a structural interpretation and used in policy experiments such as counterfactual pricing exercises,alternative explanations which might give rise to similar consumer behavior must be ruled out. We develop a flexible model of heterogeneity which can be given a semi-parametric interpretation and rule out alternative explanations for positive state dependence such as autocorrelated choice errors, consumer search, or consumer learning.

    Improving the Numerical Performance of Static and Dynamic Aggregate Discrete Choice Random Coefficients Demand Estimation

    Full text link
    Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/93649/1/ECTA8585.pd

    Pharmacogenomics of blood lipid regulation

    Full text link
    Blood lipids are important modifiable risk factors for coronary heart disease and drugs target different lipid fractions. Considerable efforts have been made to identify genetic variants that modulate responses to drugs in the hope of optimizing their use. Pharmacogenomics and new biotechnologies now allow for meaningful integration of human genetic findings and therapeutic development for increased efficiency and precision of lipid-lowering drugs. Polygenic predictors of disease risk are also changing how patient populations can be stratified, enabling targeted therapeutic interventions to patients more likely to derive the highest benefit, marking a shift from single variant to genomic approaches in pharmacogenomics.IRS

    Historique et problématique du régime de négociation collective dans le secteur de la santé et des services sociaux

    Get PDF
    Dans cet article, les auteurs font d'abord l'historique de la nĂ©gociation collective dans le secteur de la santĂ© et des services sociaux. AprĂšs avoir rappelĂ© que le Code du travail ne constitue pas un bon cadre lĂ©gislatif pour cette nĂ©gociation puisqu'il n'a pas Ă©tĂ© conçu Ă  cette fin, les auteurs soulignent les principales caractĂ©ristiques d'une nĂ©gociation avec l'État. Enfin, ils exposent les choix Ă  faire quant Ă  la centralisation ou la dĂ©centralisation des nĂ©gociations, et quant aux modes de rĂšglement des diffĂ©rends.Abstract: In this article, the writers begin by giving an overview of the history of collective negotiations in the health and social services sector. After noting that the Labour Code does not constitute the appropriate legislative framework for such negotiations since this legislation was not adopted with such a purpose in mind, the writers go on to describe the fundamental characteristics of negotiations entered into with the State. Lastly, the writers describe the relative merits of centralized and decentralized negotiations as well as those of the various modalities available for resolving disputes

    To put an end to car dependence - Final report of the scoping review of the literature on the modal shift from the car to alternative modes 2010-2020

    Get PDF
    This research answers the following question: what are the main modal shift strategies discussed in the literature of the last 10 years? It also undertakes to analyze the impacts of each of the strategies present in the literature. It presents a scoping review of the literature aiming to draw an up-to-date portrait of the abundant literature on modal shift in order to synthesize it and present it in an organized manner and draw conclusions for future research and transport and development policies aimed at reducing automobile dependence and inducing a modal shift from the automobile to alternative modes of transport. We reviewed 2,872 studies published between 2010 and 2020 and retained 108 that we analyzed in detail. More than two thirds of studies report positive results of modal shift from the car towards alternative mobility. This leads us to believe that it is possible to implement public policies to facilitate modal shift and thus help reduce car dependence. A large majority of research on public transport reports positive examples. However, for studies on active transportation, we note that almost all of the research (92%) reports successes. By paying attention to the degree of coercion of the interventions investigated in the literature, we see that the “carrot” measures which seek to induce the modal shift by offering a benefit are more successful than the “stick” type measures which aim to restrict certain choices (pricing, tolls, reduction of parking spaces). However, research on the “carrot and stick” combination approach reports the most positive results. This leads us to conclude that research on this type of intervention should continue to be developed, even encouraged, and to suggest that public decision-makers take into account the beneficial effects for modal shift resulting from the combination of the two types of interventions simultaneously “carrot and stick”

    Effect of curing pressure on machinability of carbon fiber composite

    Get PDF
    The increasing use of composite materials in aerospace structures and their associated manufacturing and machining processes have shown the need to reengineer traditional tools. This study aims to provide an understanding of the relationship between the manufacturing parameters of carbon fiber/epoxy composites and their machinability. The main objective is to establish a new predictive model for cutting forces during machining as a function of curing pressure, cutting speed and feed rate. The research methodology is based on a multifactorial design of experiments, with input factors being the curing pressure, the feed rate, and the cutting speed. To examine the effect of the composite curing pressure, correlations between the curing pressure and the void content, as well as between the curing pressure and the mechanical properties, are evaluated. The cutting forces are then predicted based on the curing pressure and the cutting parameters

    Pour en finir avec la dĂ©pendance automobile : rapport final de l’étude de la portĂ©e de la littĂ©rature sur le transfert modal de la voiture aux modes alternatifs 2010-2020

    Get PDF
    Cette recherche rĂ©pond Ă  la question suivante : quelles sont les principales stratĂ©gies de transfert modal discutĂ©es dans la littĂ©rature des 10 derniĂšres annĂ©es. Elle entreprend aussi d’analyser les impacts de chacune des stratĂ©gies prĂ©sentes dans littĂ©rature. Elle prĂ©sente une Ă©tude de la portĂ©e de la littĂ©rature visant Ă  dresser un portrait Ă  jour de l’abondante littĂ©rature sur le transfert modal afin de la synthĂ©tiser et de la prĂ©senter de façon organisĂ©e et d’en tirer des constats pour la recherche future et les politiques de transport et d’amĂ©nagement visant Ă  rĂ©duire la dĂ©pendance automobile et Ă  induire un transfert modal de l’automobile vers les modes de transports alternatifs. Nous avons rĂ©visĂ© 2872 Ă©tudes publiĂ©es entre 2010-2020 et en avons retenu 108 que nous avons analysĂ©es en dĂ©tail. Plus de deux tiers des Ă©tudes rapportent des rĂ©sultats positifs de transfert modal de la voiture au profit des mobilitĂ©s alternatives. Ce qui nous porte Ă  croire qu’il est possible de mettre en place des politiques publiques afin de faciliter le transfert modal et d’ainsi contribuer Ă  rĂ©duire la dĂ©pendance Ă  l’automobile. Parmi les recherches portant sur les transports en commun, une grande majoritĂ© rapporte des exemples positifs. Cependant, du cĂŽtĂ© des Ă©tudes portant sur le transport actif, nous notons que la presque totalitĂ© des recherches (92 %) rapporte des succĂšs. En portant attention au degrĂ© de coercition des interventions enquĂȘtĂ©es dans la littĂ©rature, on constate que les mesures « carotte » qui cherchent Ă  induire le transfert modal en offrant un bĂ©nĂ©fice ont plus de succĂšs que les mesures de type « bĂąton » qui visent Ă  restreindre certains choix (tarification, pĂ©age, diminution des espaces de stationnement). Cependant, les recherches portant sur la combinaison « carotte et bĂąton » rapportent les rĂ©sultats les plus positifs. Ceci nous amĂšne Ă  conclure que la recherche sur ce type d’intervention devrait continuer Ă  ĂȘtre dĂ©veloppĂ©e, voire encouragĂ©e, et Ă  suggĂ©rer aux dĂ©cideurs publics de tenir compte des effets bĂ©nĂ©fiques pour le transfert modal provenant de la combinaison des deux types d’interventions simultanĂ©ment « carotte et bĂąton »

    Pharmacogenomics of the efficacy and safety of Colchicine in COLCOT

    Get PDF
    © 2021 The Authors. Circulation: Genomic and Precision Medicine is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited and is not used for commercial purposes.Background: The randomized, placebo-controlled COLCOT (Colchicine Cardiovascular Outcomes Trial) has shown the benefits of colchicine 0.5 mg daily to lower the rate of ischemic cardiovascular events in patients with a recent myocardial infarction. Here, we conducted a post hoc pharmacogenomic study of COLCOT with the aim to identify genetic predictors of the efficacy and safety of treatment with colchicine. Methods: There were 1522 participants of European ancestry from the COLCOT trial available for the pharmacogenomic study of COLCOT trial. The pharmacogenomic study's primary cardiovascular end point was defined as for the main trial, as time to first occurrence of cardiovascular death, resuscitated cardiac arrest, myocardial infarction, stroke, or urgent hospitalization for angina requiring coronary revascularization. The safety end point was time to the first report of gastrointestinal events. Patients' DNA was genotyped using the Illumina Global Screening array followed by imputation. We performed a genome-wide association study in colchicine-treated patients. Results: None of the genetic variants passed the genome-wide association study significance threshold for the primary cardiovascular end point conducted in 702 patients in the colchicine arm who were compliant to medication. The genome-wide association study for gastrointestinal events was conducted in all 767 patients in the colchicine arm and found 2 significant association signals, one with lead variant rs6916345 (hazard ratio, 1.89 [95% CI, 1.52-2.35], P=7.41×10-9) in a locus which colocalizes with Crohn disease, and one with lead variant rs74795203 (hazard ratio, 2.51 [95% CI, 1.82-3.47]; P=2.70×10-8), an intronic variant in gene SEPHS1. The interaction terms between the genetic variants and treatment with colchicine versus placebo were significant. Conclusions: We found 2 genomic regions associated with gastrointestinal events in patients treated with colchicine. Those findings will benefit from replication to confirm that some patients may have genetic predispositions to lower tolerability of treatment with colchicine.info:eu-repo/semantics/publishedVersio

    Meta-analysis of genome-wide association studies of HDL cholesterol response to statins

    Get PDF
    BACKGROUND: In addition to lowering low density lipoprotein cholesterol (LDL-C), statin therapy also raises high density lipoprotein cholesterol (HDL-C) levels. Inter-individual variation in HDL-C response to statins may be partially explained by genetic variation.METHODS AND RESULTS: We performed a meta-analysis of genome-wide association studies (GWAS) to identify variants with an effect on statin-induced high density lipoprotein cholesterol (HDL-C) changes. The 123 most promising signals with p&lt;1×10(-4) from the 16 769 statin-treated participants in the first analysis stage were followed up in an independent group of 10 951 statin-treated individuals, providing a total sample size of 27 720 individuals. The only associations of genome-wide significance (p&lt;5×10(-8)) were between minor alleles at the CETP locus and greater HDL-C response to statin treatment.CONCLUSIONS: Based on results from this study that included a relatively large sample size, we suggest that CETP may be the only detectable locus with common genetic variants that influence HDL-C response to statins substantially in individuals of European descent. Although CETP is known to be associated with HDL-C, we provide evidence that this pharmacogenetic effect is independent of its association with baseline HDL-C levels.</p
    • 

    corecore